Novel mechanism-based inhibitors of influenza neuraminidase as potential anti-viral agents

基于新机制的流感神经氨酸酶抑制剂作为潜在的抗病毒药物

• 批准号: 194717
• 负责人: Withers Stephen G
• 金额: $ 10.93万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-10-01 至 2010-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=194717&lang=en
• 关键词: Anti-Viral; Drug Development; Influenza; Inhibitor; Neuraminidase; Pandemic Preparedness

Influenza is a severe infection of the upper respiratory tract that occurs globally each year, developing in approximately 20% of the world's population. Annually, more than 3.5 million people die of influenza and over 1.3 billion are afflicted. In the US

流感是一种严重的上呼吸道感染，每年在全球范围内发生，约占世界人口的20%。每年有超过350万人死于流感，超过13亿人受到影响。在美国